secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aprea Therapeutics, Inc. (APRE)
CIK:        0001781983
Form:       8-K
Filed at:   2023-09-11T23:59:59+00:00
Accession:  0001558370-23-015621
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aprea Therapeutics updates corporate presentation for Sep 2023; details not disclosed in excerpt
--------------------------------------------------------------------------------

- Filing consists solely of an updated corporate slide deck dated September 2023.
- Presentation title indicates focus on precision oncology and synthetic lethality.
- No financial results, guidance, leadership changes, or deal announcements in the filing.
- Exhibit excerpt does not contain specific trial data or operational milestones.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781983/000155837023015621/0001558370-23-015621-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781983/000155837023015621/apre-20230911x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-015621

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer